See also this year's filing and all EDGAR filings for this company.
PDF Report 0001563463_2022_Nutralife_Biosciences_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001563463')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001563463')"} |
Graph
Absolute values for 0001563463, Nutralife Biosciences INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 449,155 |
| 1 | AssetsCurrent | 518,298 |
| 2 | PropertyPlantAndEquipment | 2,265,196 |
| 3 | remainder_Assets | 1,618,476 |
| 4 | LiabilitiesLongTerm | 360,887 |
| 5 | LiabilitiesCurrent | 5,201,654 |
| 6 | remainder_Liabilities | 1,114 |
| 7 | GeneralAndAdministrativeExpense | 1,849,371 |
| 8 | SellingAndMarketingExpense | 22,913 |
| 9 | remainder_Expenses | 3,226,979 |
| 10 | remainder_Revenues | 626,619 |
| 11 | remainder_NetIncome | -1,354,863 |
| 12 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,851,125 |
| 1 | Liabilities | 5,563,655 |
| 2 | Expenses | 5,099,263 |
| 3 | Revenues | 626,619 |
| 4 | StockholdersEquity | -712,530 |
| 5 | NetIncome | -5,827,507 |
| 6 | ComprehensiveNetIncome | -5,827,507 |
| 7 | BaseVar | 8,747,762 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.19 |
| 9 | EconomicCapitalRatio | 1.12 |
Edgar->Model Mapping
Feature Distribution
Change over Time
